Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01044667 · ClinicalTrials.gov registry record · NA
A Gastrointestinal Quality of Life Study in Lung Transplant Recipients Converted From Mycophenolate Mofetil to Myfortic
A NA study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01044667 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 3 participants.
The verdict
NCT01044667, a NA study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate gastrointestinal (GI) symptoms and health related quality of life in lung transplant recipients converted from Mycophenolate Mofetil (MMF) to Myfortic as part of standard immunosuppressive therapy.
Interventions
- BEHAVIORAL GI and Quality of Life Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01044667
The ClinicalTrials.gov registry entry for NCT01044667 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GI and Quality of Life Assessment is the first listed.
NCT01044667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01044667 about?
NCT01044667 is a clinical study titled "A Gastrointestinal Quality of Life Study in Lung Transplant Recipients Converted From Mycophenolate Mofetil to Myfortic". The primary objective of this study is to evaluate gastrointestinal (GI) symptoms and health related quality of life in lung transplant recipients converted from Mycophenolate Mofetil (MMF) to Myfortic as part of standard immunosuppressive therapy.
What is the current status of trial NCT01044667?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2010-01. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01044667?
The interventions under investigation include: GI and Quality of Life Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01044667?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.